Soluble Human Suppression of Tumorigenicity 2 Is Associated With Endoscopic Activity in Patients With Moderate-To-Severe Ulcerative Colitis Treated With Golimumab
Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756284819869141
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2019
Authors
Publisher
SAGE Publications